New Treatments

Transforming TB Treatment

TB Alliance is leading the global effort to develop faster, simpler, and more effective cures for all forms of TB.

Learn More:

TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD

Elizabeth Glaser Pediatric AIDS Foundation (EGPAF): Advancing Child Health, TB/HIV Integration, and Innovation in the Global TB Response

Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments

Reaching Further

A new generation of faster, simpler TB cures is taking shape today. Read more from our 2025 Annual Report about our work to advance innovative science, including the development of a new treatment regimen and long-acting injectables, while expanding global access to lifesaving cures.

Learn More

Meeting with Global TB Stakeholders

Our 2026 Global TB Stakeholders Meeting brought together partners, advocates, and global health leaders with a focus on the promise of and significant progress in establishing a pathway to TB Alliance’s 1×1 vision for the future of TB treatment – one-month treatment for active TB and one-day treatment for latent TB infection.

Learn more

The Latest from TB Alliance

Impact of BPaL/M: Shorter Care. More Lives Saved. Lower Costs.

Findings from Johns Hopkins University research show that BPaL/M is on track to save 191k lives and US$1.29B by 2034—while boosting treatment completion and success. Read more.

TB By The Numbers

Million

Tuberculosis (TB) is a global pandemic, killing someone approximately every 24 seconds — about 1.3 million people every year.

Get the Facts

6-Months

Too many people with TB are still given older regimens that take too long to cure, are too complicated to administer, and can be toxic. We are changing this!

How We’re Doing It

+ Projects

Promise in the pipeline means new hope in stopping TB.

Explore our Pipeline